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Abstract Stem cells maintain homeostasis in all regener-
ating tissues during the lifespan of an organism. Thus, age-
related functional decline of such tissues is likely to be at
least partially explained by molecular events occurring in
the stem cell compartment. Some of these events involve
epigenetic changes, which may dictate how an aging gen-
ome can lead to differential gene expression programs.
Recent technological advances have made it now possible
to assess the genome-wide distribution of an ever-in-
creasing number of epigenetic marks. As a result, the
hypothesis that there may be a causal role for an altered
epigenome contributing to the functional decline of cells,
tissues, and organs in aging organisms can now be
explored. In this paper, we review recent developments in
the field of epigenetic regulation of stem cells, and how this
may contribute to aging.
Introduction
Aging is associated with a progressive decline in function
of adult tissues and organs observed in all mammals. Adult
stem cells have now been characterized in almost all
mammalian tissues, including blood, skeletal muscle,
intestine, skin, and brain. These tissue-specific stem cells
possess self-renewal potential and the ability to generate
mature cells: characteristics they need in order to maintain
tissue homeostasis and regeneration of the tissue after
stress or cell loss. Within many aged tissues, a loss of the
regenerative capacity of adult stem cells has been docu-
mented. Therefore, impaired stem cell function, more than
intrinsic changes in differentiated cells, has been consid-
ered as a driver of the aging process of multiple regener-
ating tissues, and as such may contribute to organismal
aging. Such stem cell-intrinsic events could theoretically
involve either genetic or epigenetic changes. Whereas the
role of an accumulation of genetic lesions in stem cell
functioning during aging has been recently reviewed else-
where (Behrens et al. 2014), in the current manuscript we
focus on the role of age-associated epigenetic changes.
‘‘Epigenetics’’ is a term used to classify heritable changes
of gene expression that are not attributed to changes in the
DNA sequence (Goldberg et al. 2007). Due to the funda-
mental role of epigenetics in the regulation of gene
expression and the putative reversibility of such epigenetic
marks, there is an increasing interest in the role of epige-
netic processes as mediators of the aging process of stem
cells. In this review, we discuss the biology of stem cell
aging with a particular focus on the epigenetic contribution
to the aging process. We briefly explain current methods to
evaluate epigenetic marks in the context of biological aging
and discuss to what extent these have revealed a common
epigenetic pattern in stem cell aging.
Do aging stem cells contribute to the functional
decline of organs?
As individuals age, there is a gradual loss of homeostasis of
most tissues and, as a consequence, a decline in organ
function. A large body of data suggests that in many tissues
age-associated loss of homeostasis is caused by an age-
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related decline in the ability of stem cells to replace
damaged cells, (reviewed in Rando 2006; Drummond-
Barbosa 2008; Liu and Rando 2011). For example, skeletal
muscle possesses remarkable regenerative ability upon
injury, a process that is mediated by the resident muscle
stem cells. However, muscle stem cells isolated from aged
animals have a higher propensity to undergo fibrogenic
differentiation (Brack et al. 2007). As a result, upon aging
there is an increase in tissue fibrosis and the subsequent
aged-related reduction in the mass of muscle tissue con-
tributes to an impaired motor activity in the elderly. Sim-
ilarly, aging in the nervous system leads to the loss of
neuronal stem cells (NSCs) (Molofsky et al. 2006). NSCs
in the adult brain give rise to new granule layer neurons
that integrate into functional neuronal circuits (Song et al.
2002), supporting processes such as learning and memory
formation (Clelland et al. 2009), which are often impaired
as individuals age. Also in the skin, melanocyte stem cells
that pigment new hair drop in number upon aging (Maslov
et al. 2004), leading to the very common phenotype
observed in the elderly, hair loss and graying (Nishimura
et al. 2005). However, in mammals, not every organ is
directly dependent on stem cell activity. Aging-related
alterations in organs like eyes, inner ears, or bones are
more difficult to attribute to impaired stem cell activity.
Retinal stem cells can potentially account for age-related
diseases like macular degeneration, but not for the changes
in corneal curvature or in the condensation of the vitreous
gel that cause alteration in refraction and decreased sight
capacity in elderly. Similarly, ear sensory cells do not
regenerate if lost (Groves 2010); therefore, aged-associated
loss of hearing has so far not been associated to stem cell
exhaustion.
Understanding the basic properties of the various types
of tissue-specific stem cells and cataloguing the molecular
changes that accumulate in these cells as they age is of
great interest. In particular, insight into molecular changes
that could potentially be reversible, such as epigenetic
alterations, may open options to develop therapeutic
approaches for age-related diseases based on interventions
to delay or prevent stem cell aging.
Functional and molecular manifestations of stem
cell aging
In the section above, we introduced the aged-associated
decline of function at the level of tissues and organs. In the
following sections, we discuss the main functional mani-
festation and molecular changes that occur in several
regenerating tissues as stem cells age. In particular, we will
focus on age-related changes that appear to occur com-
monly versus changes that are tissue specific.
Stem cell pool size
In almost all mammalian tissues that are capable to
regenerate, the number of adult stem cells is affected by
aging. However, the directionality of this change is vari-
able. Stem cells in the hematopoietic tissue have been
reported to increase in number (de Haan and Van Zant
1999), and this age-dependent expansion of HSCs is a
transplantable, cell-intrinsic aspect of hematopoietic stem
cells. On the contrary, skin and muscle stem cells display
an age-dependent decrease in number (Nishimura et al.
2005; Renault et al. 2002). In brain, changes in the neu-
ronal stem cell pool appear to be region-specific (Kuhn
et al. 1996; Maslov et al. 2004; Hattiangady and Shetty
2008). Currently, we know very little about how stem cell
pool size in these various tissues is actually regulated.
However, despite the diverse directionality of the change in
stem cell pool size, alterations in the numbers of stem cells
during aging suggest that deregulation of self-renewal and
cell fate programs, i.e., a loss of control of stem cell pool
size, might be a common molecular event occurring during
aging. It is worth considering, however, that measurements
of stem cell compartment size is confounded by the current
inability to purify stem cells to homogeneity, as well as the
lack of adequate models to test the function of many stem
cell types.
Impaired functionality and altered lineage
commitment
The decline in stem cell functionality is a shared feature
among the majority of adult stem cell compartments.
Defects of aged HSCs in long-term reconstitution of the
immune system have been demonstrated in competitive
transplantation assays (Kamminga et al. 2005; Rossi et al.
2005). Neurogenesis potential of neuronal stem cells in the
nervous system declines with age (Bondolfi et al. 2004;
Enwere et al. 2004). Similarly, aged muscle satellite cells
display impaired muscle regeneration after injury (Conboy
et al. 2003; Carlson and Conboy 2007). The loss of func-
tionality in a stem cell compartment directly translates into
a decline in the function of progenitors cells and ultimately
into an altered differentiation program. Thus, an aging-
associated feature shared among many adult stem cell
compartments is the aberrant lineage specification of stem
cell progeny. Within the hematopoietic system, stem cells
from both old humans and old mice show an increased
propensity to differentiate along the myeloid, rather than
the lymphoid lineage (Sudo et al. 2000; Rossi et al. 2005;
Dykstra et al. 2007; Cho et al. 2008). In the brain, there is
an increased production of astrocytes (astroglial lineage
skewing) (Peinado et al. 1998). Aged muscles are charac-
terized by the increased tendency of satellite cells to
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convert from myogenic to fibroblastic and adipogenic lin-
eages (Taylor-Jones et al. 2002; Brack et al. 2007). The
accumulation of abnormal progenies in all the tissues
reported above critically contributes to the gradual deteri-
oration of tissue structure and function associated with
aging.
Molecular alterations underling stem cell aging
Several molecular changes, including perturbation of sig-
naling pathways, mitochondrial dysfunction, metabolic and
cell energetic deregulation, have been implicated in tissue-
specific aging patterns and have been extensively reviewed
elsewhere (Lopez-Otin et al. 2013). In general, cell-in-
trinsic changes can be broadly grouped into two classes:
those that are genetic, and therefore typically irreversible,
versus those that are epigenetic. The extent to which
mostly irreversible genomic changes (including nuclear
and mitochondrial DNA damage and telomere shortening)
contribute to stem cell aging is an active area of investi-
gation and has been extensively reviewed elsewhere
(Adams et al. 2015). Mouse models involving DNA repair
proteins have shown that an aging-like phenotype is
accelerated in the presence of increased DNA damage
(reviewed in Garinis et al. 2008). However, so far no
experimental evidence has been provided which demon-
strates that repressing the occurrence of DNA mutations
leads to an extension of life span.
DNA mutations can also occur in genes coding for
epigenetic modifiers, leading to an altered epigenetic reg-
ulation and possibly altered fate programs. Interestingly,
common DNMT3A mutations have been recently descri-
bed to arise early in the development of acute myeloid
leukemia, a type of leukemia that preferentially occurs in
the elderly. DNMT3a mutations appear to lead to a clonally
expanded pool of pre-leukemic stem cells from which
AML evolves (Shlush et al. 2014).
Whereas most genetic changes that occur in somatic
stem cells are believed to be irreversible, molecular chan-
ges that affect epigenetic moieties are potentially rever-
sible. What are the indications that such epigenetic changes
are associated with stem cell aging?
Epigenetic control of stem cell regulation
Epigenetics is the study of phenotypes or gene expression
patterns that are heritable through cell divisions, but remain
independent of DNA sequence (Berger et al. 2009; Gold-
berg et al. 2007; reviewed in Bonasio et al. 2010). Epige-
netic regulation is required for the establishment and
maintenance of biological states (Grewal and Klar 1996;
Cavalli and Paro 1998; Martin and Zhang 2007). Thus,
while in differentiated-end stage-cells epigenetic regulation
is mainly used to regulate ongoing cellular processes, in
stem cells the implications of the epigenome are wider.
During a self-renewing division, a stem cell must not only
replicate its genome flawlessly but also must copy all the
relevant epigenetic markers, deposited by a large number
of writers and erasers, to at least one of the two daughter
cells, in the timeframe of a single cell division. Epigenetic
regulation in adult stem cells must ensure the co-occur-
rence of self-renewal programs together with instructions
for differentiation into cells with distinct potentials and, in
some instances, into a large set of mature cells of different
lineages with vast functional heterogeneity. Thus, epige-
netic alterations that arise in stem cells can be amplified
through self-renewal programs and propagated to the pro-
geny upon differentiation. Infidelity in the epigenetic stem
cell machinery in stem cells could result in detrimental
losses or gains of a plethora of marks during aging (Fig. 1).
DNA methylation
Epigenetic regulation can occur at different levels. At the
DNA level, epigenetic modification is shaped by the
addition or removal of a methyl group or hydroxymethyl
group at the 5th carbon atom of cytosine. DNA methyl-
transferase enzymes are responsible for both the estab-
lishment (DNMT3A and DNMT3B) and maintenance
(DNMT1) of methylated nucleotides. Many studies have
documented a role for these enzymes in balancing self-
renewal and differentiation in multiple adult stem cell
compartments (reviewed in Beerman and Rossi 2015). The
aberrant stem cell functioning caused by dysregulation of
DNA methylation leads to phenotypes frequently mirroring
those observed with aging. Loss of Dnmt1 in HSCs leads to
dysregulation of lineage output, with a skewing towards
myelopoiesis (Broske et al. 2009), a phenotype largely
associated with HSCs aging. Similarly, Dnmt3a ablation in
HSCs predisposes mice to develop a spectrum of myeloid
and lymphoid malignancies, and Dnmt3a-KO-derived
myeloid malignancies and T cell acute lymphocytic
leukemia/lymphoma show distinct methylation aberrations
(Mayle et al. 2015). Interestingly, Dnmt3a has been found
to be slightly but significantly downregulated with age
(Sun et al. 2014).
The gold standard for direct analysis of DNA methyla-
tion is the sequencing-based quantification of cytosine
methylation following bisulfite conversion, which allows
identification and quantification of DNA methylation at
single nucleotide resolution. A description of current
techniques and methods used for analysis of DNA
methylation has been recently reported (Plongthongkum
et al. 2014). An ever-increasing effort has been made
towards the application of assays aimed to quantify DNA
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methylation in a limited amount of input material
(Table 1), such as highly purified populations of stem cells.
Experiments that use low numbers of cells are predicted to
reduce bias originating from cell-to-cell variability, even
within a relatively homogeneous cell population. Early
studies examined global DNA methylation patterns in aged
tissues, and largely demonstrate age-associated hypo-
methylation (Wilson and Jones 1983; Wilson et al. 1987;
Heyn et al. 2012; Florath et al. 2014; Jung and Pfeifer
2015). Nonetheless, global DNA hypo-methylation does
not exclude the possibility that individual loci become
hypermethylated during aging. Indeed, along with a
Fig. 1 Epigenetic alterations in aging of stem cells. Upon multiple
cell divisions that occur as a function of time, infidelity in exact
replication of the epigenome to daughter cells might occur. Both
detrimental losses and gains of epigenetic modifications can thus be
amplified within the stem cell pool and propagated to the progeny
upon differentiation
Table 1 Analysis of the epigenome: recent methods for single cell or ultra-low-input assays
Assay Developer Input material
Nano-ChIP-seq Adli and Bernstein
2011
10,000 cells for H3k4me3 histone mark
Linear DNA amplification (LinDA) Shankaranarayanan
et al. 2011
For transcription factors using 5000 cells and for the H3K4me3
histone modification using 10,000 cells




10,000 for histone marks
ChIPmentation Schmidl et al. 2015 For several histone marks 10,000 cells per IP, and 100,000 cells
for transcription factors
Single-cell ChIP-seq Rotem et al. 2015 One cell. ChIP-seq for H3k4me3 and H3k4me2
Single-cell reduced-representation bisulfite
sequencing scRRBS
Guo et al. 2015 One cell. Non-targeted enrichment DNA methylation analysis
Low-input and single-cell whole-genome bisulfite
sequencing (lWGBS, scWGBS)
Farlik et al. 2015 High-throughput bisulfite sequencing assay for low-input and
single-cell samples
Single-cell bisulfite sequencing scBS-seq Smallwood et al.
2014
One cell. Targeted enrichment DNA methylation analysis
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genome-wide analysis of the global DNA methylation
landscape, several studies report have uncovered locus-
specific DNA hyper-methylation associated with aging
tissues (Maegawa et al. 2010; Rakyan et al. 2010; Zyko-
vich et al. 2014). Interestingly, DNA methylation of a
limited set of specific loci has been hypothesized to provide
biomarkers for the aging process (Horvath 2013; Weidner
et al. 2014). It is worth noticing that studies in neuronal,
hematopoietic, and skin stem cells in which the DNA
methylome was correlated with the transcriptome revealed
that altered DNA methylation profiles not always directly
correlated with altered transcription in stem cells (Guo
et al. 2011; Bock et al. 2012; Beerman et al. 2013; Sun
et al. 2014).
Histone variants, histone modifications, and higher
order chromatin structure
Core histones proteins within a nucleosome can be sub-
stituted by several variants. Each variant histone contains
specific physical properties, which differentially regulate
expression of nearby DNA sequences. Very little is known
about the contribution of different histone variants to the
aging process. Beyond different histone variants, a next
layer of epigenetic regulation occurs at histone tails that
can be modified by an array of post-translational modifi-
cations, including acetylation, methylation, ubiquitylation,
phosphorylation, sumoylation, ribosylation, and citrullina-
tion. These post-translational histone modifications affect
transcription both directly, through changes in higher order
chromatin structures, and indirectly, by recruitment of
downstream effectors. Current techniques to analyze the
modification of the histone tails and their implication in the
aging process will be discussed into more detail in the next
section. The combined effect of all these epigenetic
mechanisms ultimately alters the higher order structure of
the chromatin itself and the position of chromatin in the
cell nucleus, allowing the recruitment or dismissal of
transcription factors.
Substantial efforts have been made to understand the
higher, three-dimensional genome organization within the
nucleus. Chromosome conformation capture allows to
analyze physical contacts between different regions of a
chromosome and between the different chromosomes in
cell populations (Dekker et al. 2002). In the past year, 4C,
5C, and Hi-C techniques have added new layers of infor-
mation to the structure of chromosomes (reviewed in
Cattoni et al. 2015). The development of single-cell
approaches to reach single-cell, high-throughput, and high-
resolution maps will be of great relevance as to what extent
the 3-dimensional chromatin architecture in a nucleus of an
aged (stem) cell is different from a young cell, and if so,
whether or not this contributes to impaired stem cell
functioning.
A third layer of epigenetic information is provided by
nucleosome positioning and nucleosome occupancy.
Recently, data have suggested that the variation in the total
number of histone proteins may be altered during aging.
The expression of core histones has been found to be
reduced during replicative aging in yeast (Feser et al.
2010), as well as in aged muscle stem cells (Liu et al.
2013). Interestingly, increasing the cellular supply of his-
tones increased the replicative lifespan of yeast by up to
50 % (Feser et al. 2010). The molecular mechanisms
underlying this process, the genome-wide consequences of
reduced nuclear histone content, and the mechanisms by
which core histone expression levels are transferred to the
daughter cells are still to be elucidated. Nonetheless, it is
interesting to hypothesize that histone availability may
have direct consequences on the epigenetic landscape of
histone modifications and on transcription factor activity,
as they compete with nucleosomes for binding to DNA.
Epigenetic regulation by histone modifications
We will now focus in more detail on the epigenetic regu-
lation by the spatial–temporal chemical modifications at
the histone tails, and how these change upon aging.
Before the advent of genome-wide techniques to study
the epigenome, research had been mainly focused on
investigating whether specific histone modifications glob-
ally decreased or increased upon aging. These studies
typically used Western blotting or immunostaining in order
to directly quantify the amount of specific histone modifi-
cations in a given cell population. However, with this
approach no information can be retrieved concerning dif-
ferentially affected loci. Chromatin immunoprecipitation
followed by high-throughput sequencing (ChIP-seq) is
nowadays the standard technique for identifying genome-
wide loci and biochemical modifications of chromatin-
bound proteins and histone modifications. Promoters can
feature multiple activating and repressive marks, although
only few are typically assessed in a single experiment.
Together with promoters, distal enhancers refine timing
and extent of gene expression. Active or repressive
enhancers are marked by specific chromatin moieties that
can be identified in ChIP-seq analyses.
Currently, there is great interest in profiling enhancer-
associated chromatin features in order to produce genome-
wide maps of regulatory elements of clusters of genes. An
outstanding contribution to this field has recently been
provided by the Encyclopedia of DNA Elements
(ENCODE), a public research project launched by the US
National Human Genome Research Institute (NHGRI) in
September 2003 (Feinglod Science 2004). As a follow-up
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of the Human Genome Project, ENCODE is ultimately
dedicated to identify all functional elements in the human
genome. In the Roadmap Epigenomics Project, epigenomic
information has now been gathered for 127 cell types from
most human tissues (Farh et al. 2015; Gjoneska et al. 2015;
Leung et al. 2015; Polak et al. 2015; Roadmap Epige-
nomics et al. 2015; Ziller et al. 2015). This has resulted in
the identification of hundreds of thousands of enhancer-like
regions in the mammalian genome that regulate gene
expression at long range. Although at present it is not yet
feasible to determine how many features are required for a
minimal representation of the epigenome, the consortium
has focused so far on DNA methylation, six histone mod-
ifications (H3K4me1, H3K4me3, H3K9me3, H3K9ac,
H3K27me3, and H3K36me3), and chromatin accessibility.
The emerging and may be not too surprising picture is that
combinations of multiple modifications predict gene
activity in ways that a single type of modification does not.
Although these data provide a massive amount of epi-
genetic information in a large set of human cell types, it is
important to notice that these experiments, and indeed most
studies, are still based on ChIP-seq protocols that require a
large numbers of cells (*10e6) as starting material. This
limitation precludes the analysis of rare primary stem cell
populations. Therefore, in recent past, attempts have been
made to optimize new protocols suitable for low-input
ChIP-seq. Some of the recent methods for single cell or
ultra-low-input assay for the study of histone modifications
and DNA methylation are summarized in Table 1. Chal-
lenges that need to be overcome relate to the fact that PCR
amplification from limited ChIP input material more easily
leads to amplification artifacts and duplicate reads, and to a
reduced complexity of the immunoprecipitated material
recovered. In addition, different bioinformatic approaches
are used to analyze and present data, which ultimately
results in substantial discordance of conclusions between
seemingly similar studies generated from different
laboratories.
Do histone modifications alter during stem cell
aging?
As mentioned in the previous sections, the direct analysis
of histone modification in rare adult stem cell populations
during aging has been challenging for a long time, as most
of chromatin IP protocols require a high number of cells as
a starting material. Consequently, as of to date only two
recent studies have addressed whether an altered epigenetic
regulation of histone modifications in mammalian stem
cells is associated with aging. However, although this
review focuses on epigenetic profiling in stem cell aging in
mammals, it is important to consider that global loss or
gain of histone modifications during aging have been
reported in other model organisms (reviewed in Benayoun
et al. 2015).
Recently, Sun et al. profiled two chromatin marks
associated with active transcription, H3K4me3 and
H3K36me3, and the repressive mark H3k27me3 in young
and old HSCs using low-input ChIP-seq (Sun et al. 2014).
Their analysis revealed that old HSCs exhibited a slight
increase in the genome-wide number of H3K4me3 peaks,
although no differences in expression levels of the various
H3K4 methyltransferases were detected. Also, some
H3K4me3 domains became broader upon aging. Interest-
ingly, broad H3K4me3 domains have been reported to
mark genes that are important for cell identity (Benayoun
et al. 2014). Therefore, spreading of H3K4me3 during
HSCs aging could account for the increase self-renewal
and loss of lineage differentiation observed in aged HSCs.
In contrast to what has been observed in HSCs, examina-
tion of the same H3K4me3 mark in muscle satellite cells
showed few or no differences between cells isolated from
young or aged mice (Liu et al. 2013).
The repressive Polycomb-mediated H3k27me3 mark,
aged HSCs showed a similar number of peaks in aged
compared to young HSCs, but these peaks appeared to
become broader and more intense upon aging (Sun et al.
2014). This same effect was also observed in old muscle
stem cells (Liu et al. 2013), both at the TSS and in inter-
genic regions. It is interesting to note that while the
increase in H3k27me3 in activated versus quiescent muscle
stem cells in young mice correlated with an increase in the
expression of the H3K27 methyltransferase Ezh2, the
accumulation of H3k27me3 in aging did not correlated
with changes in the expression of neither Ezh2 nor with the
H3K27 demethylase Jmjd3. Also, over 30 % of the genes
that acquired H3K27me3 at their TSSs with age were not
expressed in either young or old muscle stem cells, sug-
gesting that the gain of the repressive H3K27me3 mark can
underlie other mechanisms different from transcription
suppression, and might be driven by processes that do not
include canonical methyltransferases or demethylases (for
example, decreased histone turnover and preferential
accumulation of some histone marks).
As pointed out before, it is important to note that at
present it is not trivial to cross-compare ChIP-Seq datasets
generated from different groups, due to the huge variety of
algorithms and custom-made pipelines. While commonly
used peak calling algorithms identify whether a locus is
being covered or not by a specific histone marks, it has
become relevant also to use pipelines capable of identify-
ing the extent to which individual loci are covered by
different histone marks. Due to these issues, and due to the
fact that at present only two studies have reported ChIP-seq
profiles in aged stem cells (Sun et al. 2014; Liu et al. 2013),
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it is premature to conclude whether or not a common
epigenetic stem cell signature exists in aged stem cells
from different tissues.
Mouse models to unravel the mechanism
of epigenetic regulation
Next to biochemical assays to directly study chromatin
modifications, epigenetic regulation in stem cells can be
investigated using animal models in which enzymes
responsible for the deposition or removal of histone marks
(chromatin modifiers) are disrupted. This review will now
focus on some of the most relevant findings generated from
these studies.
The H3K27 methylation mark is added by the Polycomb
repressive Complex 2 (PRC2), a complex that includes
EED, SUZ12, and the catalytically active subunits EZH2/1.
Alterations in expression enzymes involved in the transfer
or removal of the methyl group on the lysine 27 of histone
H3 have been shown to modulate organismal longevity in
models other than mouse (reviewed in Benayoun et al.
2015; Jin et al. 2011; Maures et al. 2011; Ni et al. 2012;
Siebold et al. 2010). In mammals, no studies have been
reported that show that lifespan can be extended by per-
turbation of expression of epigenetic enzymes, but the
effect of such proteins on (lifespan of) adult stem cells is
well established. Most of our knowledge on the role of the
PcG complexes in stem cells is based on studies in HSCs.
For example, the PRC1 subunit Bmi-1 was shown to play
an essential role in the generation of self-renewing adult
HSCs (Park et al. 2003). Similarly, the Cbx7-PcG subunit
was shown to regulate the balance between self-renewal
and differentiation (Klauke et al. 2013). Overexpression of
Ezh2 in HSCs prevents stem cell exhaustion during serial
transplantation (Kamminga et al. 2006). A similar role of
Ezh2 has been recently described in muscle satellite cell
self-renewal (Woodhouse et al. 2013). Conversely, loss of
Ezh1 induces significant depletion of adult HSCs (Hidalgo
et al. 2012).
Whereas the Polycomb group proteins are predomi-
nantly involved in histone methylation and lead to gene
repression, histone acetylation, which is associated with
transcriptional activation, is controlled by the opposing
activities of histone acetyltransferases (HATs) and histone
deacetylases (HDACs). Although direct manipulation of
HAT, and HDACs in stem cell with regard to age has not
been reported yet, both HATs and HDACs have been
implicated in modulating lifespan in mammals. Recent
studies in transgenic mice overexpressing the histone
deacetylase Sirtuin-1 in the brain showed significant life
span extension, supporting a role for histone acetylation in
health and lifespan (Satoh et al. 2013). Also, a role of the
deacetylase Sirt6 in regulating mammalian longevity has
been demonstrated. Mice carrying a constitutive deletion of
Sirt6 show reduced lifespan and premature aging, while the
overexpression of Sirt6 significantly increased lifespan in
male mice (Mostoslavsky et al. 2006; Kanfi et al. 2012).
The major mechanism of action of the HDACs is the
deacetylation of the histone tails and the consequent tran-
scriptional repression. However, it has also been shown
that HDACs may exert their pro-longevity role by pro-
moting increased genomic stability (Oberdoerffer et al.
2008; Wang et al. 2008; Toiber et al. 2013; Van Meter
et al. 2014). A link between HATs and aging has also been
provided in a progeroid mouse model (HGPS) where the
decreased association of HATs with the nuclear periphery
showed decreased H4K16ac and decreased lifespan
(Krishnan et al. 2011). Interestingly, low H4K16ac levels
have been correlated with aging in mouse hematopoietic
stem cells (Florian et al. 2012). To what extent these
lifespan changes result from stem cell-specific effects
remains to be determined. It would therefore be of great
interest to further investigate the role of HATs and HDACs
during the aging of the multiple types of adult stem cells,
especially as a potential therapeutic intervention aimed to
selectively target these enzymes could contribute to pre-
vention of aging-related stem cell impairment, and possibly
organismal aging.
The genetics of epigenetics
It is clear that epigenetic changes occur in cells as they age,
and it appears plausible that such epigenetic changes con-
tribute to the aging process. However, it is also interesting
to notice that the rate of aging is quite distinct between
genetically distinct individuals, or between different strains
of mice (Yuan et al. 2009). Thus, a fascinating question in
the field is whether it is possible that some of the differ-
ences in epigenetic marks that arise during stem cell aging
are in fact controlled by genetic polymorphisms. Such
polymorphisms could, for example, reside in loci encoding
for the many epigenetic writers and erasers (thus affecting
enzymatic activity) or in non-coding regulatory loci.
Studies in humans have contributed to the identification of
quantitative trait loci (QTLs) or polymorphisms that affect
histone modifications or RNA polymerase II occupancy
(McVicker et al. 2013; Grubert et al. 2015). As part of the
Roadmap Epigenomics Consortium, the integrative analy-
sis of 111 reference human epigenomes and the impact of
DNA sequence and genetic variation on epigenomic state
was investigated. From this analysis, it appeared that
indeed histone modifications and DNA methylation can be
predicted by the underlying DNA sequence using DNA
motifs analysis in ES cells. Moreover, allelic bias in both
402 S. R. Krauss, G. Haan: Epigenetic perturbations in aging stem cells
123
transcript levels and epigenomic marks was found for each
epigenome analyzed (Roadmap Epigenomics et al. 2015).
While studies from the ENCODE consortium were
carried out in human cells, other mammalian models can
also be used. For example, the use of genetically diverse
inbred mouse strains with different lifespans allows quan-
titative trait locus analyses to determine the genomic
locations of loci that are associated with the aging process.
Early studies tested a subset of the BXD (C57BL/
6J 9 DBA/2J) recombinant inbred panel of mice for
lifespan (de Haan et al. 1998), and demonstrated that intra-
strain variability of lifespan appeared to be genetically
controlled. This suggested the presence of loci that induce
individual variability among members of an inbred strain
of mouse. Such loci would be predicted to encode for
epigenetic modifiers, where polymorphisms would result in
robust or disorganized epigenetic memory. More recently,
other QTLs associated with aging in mice have been
mapped (Klebanov et al. 2001; Miller et al. 2002).
Therefore, it would be highly interesting to search for and
identify the molecular nature of genetic loci that control the
extent of epigenetic regulation in stem cells as they age.
Perspectives
Aging is a complex process from which no living organism
escapes. Identifying the molecular mechanisms that con-
tribute to, if not cause, aging is a major challenge in aging
research. The possibility that epigenetic alterations in aged
stem cells contribute to aging of specific tissues and thus to
organismal aging has received an ever-increasing attention,
partly due to the appealing potential reversibility of such
epigenetic modifications. A growing body of evidence,
discussed in this review, has shown that epigenetic alter-
ations accumulate as stem cells age, although most of these
observations are often species or tissue specific. Substantial
effort is required in order to identify whether a common
epigenetic signature in aged stem cells exists. This is
gradually becoming feasible due to technological
advancements to screen multiple histone marks genome-
wide. Critical in such analysis will be the use of highly
purified and homogeneous cell populations, to rule out bias
originating from cellular heterogeneity. In most tissues,
purified stem cell populations are only available in limited
quantities and therefore they have been so far excluded
from genome-wide analyses that require high-input proto-
cols. However, this will soon change as technological
advancements will allow highly sensitive analyses using a
low number of (stem) cells. It will be very interesting to
address how the epigenome of a stem cell changed over its
lifespan that is during aging. It will also be very important
to standardize pipelines for the data analysis of genome-
wide epigenetic data. Multiple complementary efforts have
been undertaken by individual laboratories in understand-
ing how the organization of the epigenome varies across
rare cell types and different states, included aging. How-
ever, due to the early stage of low-input ChIP-seq assays
and to the fact that often custom-made pipelines were used
for the analysis of these datasets, the results are still in their
infancy and are very difficult to be cross-compared
between different laboratories. At the moment, it is not
obvious that common epigenetic stem cell aging patterns
can indeed be identified or rather whether aging at the
epigenetic level is a completely random and unpre-
dictable process. Either way, if epigenetic alterations can
be causally linked to stem cell aging, targeting of such
alterations in aged stem cells might be feasible in the near
future. This would open the possibility to reverse, at least
some, aging-associated deleterious epigenetic
modifications.
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